Don't jump in without doing some research first.
Markets sent a clear message Friday following President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to head the Department of Health and Human Services (HHS). Vaccine stocks took a nosedive,...
CMPS earnings call for the period ending September 30, 2024.
CMPS earnings call for the period ending June 30, 2024.
Down 84% from all-time highs, Compass Pathways is a beaten-down biotech stock that trades at a massive discount to consensus price target estimates in 2024.
Nothing is going wrong, but one of its peers just hit a serious snag.
Regulators were not impressed by one company's petition for approval.
Psychedelic medicines are rapidly gaining legitimacy on several fronts.
CMPS earnings call for the period ending March 31, 2024.